Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study
- PMID: 37975098
- PMCID: PMC10638127
- DOI: 10.1007/s40200-023-01311-4
Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study
Abstract
Background: Bariatric surgery is well-established to support long-term metabolic health benefits associated with considerable weight loss. Here, we aim to determine the longer-term impact of bariatric surgery on liver enzymes and associations with other metabolic improvements.
Methods: One hundred patients who underwent bariatric surgery between 2007 and 2014 were included, and changes in liver enzymes, anthropometric measures and other parameters were observed over a mean 9.8 years.
Results: At the time of surgery, the mean age was 45.4 ± 9.6 years, weight 141.2 ± 31.6 kg, and body mass index (BMI) 50.2 ± 10.1 kg/m2. Most patients underwent sleeve gastrectomy [n = 71] with a mean follow-up duration 9.8 ± 2.3 years. From baseline, alanine transaminase (ALT) reduced by 41.3% within 12 months post-operatively (36.6 ± 29.2 U/L to 21.5 ± 14.9 U/L, p < 0.001), which was sustained at recent follow-up (20.2 ± 10.7 U/L, p < 0.001). There were associated reductions in body weight, BMI, HbA1c, blood pressure and triglycerides. Patients with greater baseline ALT had the greatest reduction in ALT over follow-up.
Conclusions: Bariatric surgery is associated with rapid and sustained improvements in routine liver enzymes at 10 years, and sustained improvements in features of the metabolic syndrome.
Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01311-4.
Keywords: Bariatric surgery; Metabolic syndrome; NAFLD; Non-alcoholic fatty liver disease; Obesity; Weight loss.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Competing interestsOn behalf of all authors, the corresponding author states that there is no conflict of interest.
Similar articles
-
The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.Surgeon. 2024 Feb;22(1):e26-e33. doi: 10.1016/j.surge.2023.07.006. Epub 2023 Aug 9. Surgeon. 2024. PMID: 37567846
-
Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.Obes Surg. 2018 May;28(5):1342-1350. doi: 10.1007/s11695-017-3012-z. Obes Surg. 2018. PMID: 29119336 Clinical Trial.
-
The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.Middle East J Dig Dis. 2021 Jul;13(3):200-207. doi: 10.34172/mejdd.2021.226. Epub 2021 May 11. Middle East J Dig Dis. 2021. PMID: 36606220 Free PMC article.
-
Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.J Visc Surg. 2023 Apr;160(2S):S38-S46. doi: 10.1016/j.jviscsurg.2022.12.003. Epub 2023 Jan 30. J Visc Surg. 2023. PMID: 36725451 Review.
-
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.J Clin Med. 2021 Dec 7;10(24):5721. doi: 10.3390/jcm10245721. J Clin Med. 2021. PMID: 34945016 Free PMC article. Review.
Cited by
-
Advances in Perioperative Nutritional Management in Metabolic and Bariatric Surgery.Diabetes Metab Syndr Obes. 2025 Jul 5;18:2191-2202. doi: 10.2147/DMSO.S518912. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 40636752 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources